Rothia mucilaginosa

Last updated

Rothia mucilaginosa
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micrococcales
Family: Micrococcaceae
Genus: Rothia
Species:
R. mucilaginosa
Binomial name
Rothia mucilaginosa
(Bergan and Kocur 1982) Collins et al. 2000
Type strain
ATCC 25296
CCM 2417
CCUG 20962
CIP 71.14
DSM 20746
IFO 15673
JCM 10910
NBRC 15673
NCTC 10663
Synonyms [1] [2]
  • "Micrococcus mucilaginosus" Migula 1900
  • "Staphylococcus salivarius" Andrewes and Gordon 1907
  • Stomatococcus mucilaginosus(ex Migula 1900) Bergan and Kocur 1982

Rothia mucilaginosa is a Gram-positive, coagulase-negative, encapsulated, non-spore-forming and non-motile coccus, present in clusters, tetrads or pairs that is a part of the normal oropharyngeal flora. [3] Belonging to the family Micrococcaceae, it was first isolated from the mucous membrane of the cheek and gingiva. [4] It is an oral commensal, that has been linked to causing severe bacteremia in immunocompromised patients. [5] This bacterium has also been shown to form biofilms, similar to that of Pseudomonas aeruginosa [ clarification needed ][ citation needed ]. R. mucilaginosa is a cohabitant in the lower airways of patients with chronic lung diseases such as bronchiectasis, [5] however has been shown to elicit anti-inflammatory effects. [6]

Contents

Morphology

Rothia mucilaginosa is a Gram-positive, coagulase-negative, encapsulated, non-spore-forming and non-motile coccus, present in clusters, tetrads or pairs. [3] R. mucilaginosa can easily be confused for the bacteria from the genera Micrococcus and Staphylococcus . One way that it can be distinguished from those two is by its strong adherence to the solid medium substrate that its colonies form. Another way is by its weak or absent catalase reaction, failure to grow on 5% NaCl media or its glucose and sucrose fermentation. [3]

Pathology

Rothia mucilaginosa is a common oropharyngeal commensal bacteria that has also been detected in the lower airways of people with Bronchiectasis. Its role in chronic lung disease is complex with some studies showing it has pro-inflammatory properties [5] and others showing anti-inflammatory properties. [6] Specifically, it has been shown to induce the inhibition of the COX-2 inhibitor, which is largely related to an increased production of PGE2, which has been shown to be immunosuppressive in animal models of bacterial pneumonias and sepsis. The inhibition of COX-2 improved survival in mice, suggesting that the pathogenic effects of R. mucilaginosa are related to the induction of COX-2 [7] It is also closely associated with Bacteremia, sepsis, and endocarditis. [8]

Antibiotics

Rothia mucilaginosa is resistant to the quinolone class of antibiotics, with extreme resistance to fluoroquinolones. Sensitivity, as of 2003, is still found in trimethoprim-sulfamethoxazole, vancomycin and bacitracin. [3]

Related Research Articles

<span class="mw-page-title-main">Bronchiectasis</span> Disease of the lungs

Bronchiectasis is a disease in which there is permanent enlargement of parts of the airways of the lung. Symptoms typically include a chronic cough with mucus production. Other symptoms include shortness of breath, coughing up blood, and chest pain. Wheezing and nail clubbing may also occur. Those with the disease often get lung infections.

Bloodstream infections (BSIs) are infections of blood caused by blood-borne pathogens. Blood is normally a sterile environment, so the detection of microbes in the blood is always abnormal. A bloodstream infection is different from sepsis, which is characterized by severe inflammatory or immune responses of the host organism to pathogens.

<span class="mw-page-title-main">Inflammatory bowel disease</span> Medical condition

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, with Crohn's disease and ulcerative colitis (UC) being the principal types. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.

<span class="mw-page-title-main">Coccus</span> Round shape of certain bacteria or archaea

A coccus is any bacterium or archaeon that has a spherical, ovoid, or generally round shape. Bacteria are categorized based on their shapes into three classes: cocci (spherical-shaped), bacillus (rod-shaped) and spiral. Coccus refers to the shape of the bacteria, and can contain multiple genera, such as staphylococci or streptococci. Cocci can grow in pairs, chains, or clusters, depending on their orientation and attachment during cell division. In contrast to many bacilli-shaped bacteria, most cocci bacteria do not have flagella and are non-motile.

Staphylococcus hominis is a coagulase-negative member of the bacterial genus Staphylococcus, consisting of Gram-positive, spherical cells in clusters. It occurs very commonly as a harmless commensal on human and animal skin and is known for producing thioalcohol compounds that contribute to body odour. Like many other coagulase-negative staphylococci, S. hominis may occasionally cause infection in patients whose immune systems are compromised, for example by chemotherapy or predisposing illness.

<span class="mw-page-title-main">Lung abscess</span> Medical condition

Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities containing necrotic debris or fluid caused by microbial infection.

<i>Micrococcus</i> Genus of bacteria

Micrococcus is a genus of bacteria in the Micrococcaceae family. Micrococcus occurs in a wide range of environments, including water, dust, and soil. Micrococci have Gram-positive spherical cells ranging from about 0.5 to 3 micrometers in diameter and typically appear in tetrads. They are catalase positive, oxidase positive, indole negative and citrate negative. Micrococcus has a substantial cell wall, which may comprise as much as 50% of the cell mass. The genome of Micrococcus is rich in guanine and cytosine (GC), typically exhibiting 65 to 75% GC-content. Micrococci often carry plasmids that provide the organism with useful traits.

Bronchorrhea is the production of more than 100 mL per day of watery sputum. Chronic bronchitis is a common cause, but it may also be caused by asthma, pulmonary contusion, bronchiectasis, tuberculosis, cancer, scorpion stings, severe hypothermia and poisoning by organophosphates and other poisons. Massive bronchorrhea may occur in either bronchioloalveolar carcinoma, or in metastatic cancer that is growing in a bronchioloalveolar pattern. It commonly occurs in the setting of chest wall trauma, in which setting it can cause lobar atelectasis.

Porphyromonas gingivalis belongs to the phylum Bacteroidota and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.

Capnocytophaga is a genus of Gram-negative bacteria. Normally found in the oropharyngeal tract of mammals, they are involved in the pathogenesis of some animal bite wounds and periodontal diseases.

<span class="mw-page-title-main">Erdosteine</span> Chemical to treat chronic bronchitis

Erdosteine is a molecule with mucolytic activity. Structurally it is a thiol derivative characterized by the presence of two thiol groups. These two functional sulfhydryl groups contained in the molecule are released following first-pass metabolism with the conversion of erdosteine into its pharmacologically active metabolite Met-I.

<i>Staphylococcus capitis</i> Species of bacterium

Staphylococcus capitis is a coagulase-negative species (CoNS) of Staphylococcus. It is part of the normal flora of the skin of the human scalp, face, neck, scrotum, and ears and has been associated with prosthetic valve endocarditis, but is rarely associated with native valve infection.

<i>Staphylococcus</i> Genus of Gram-positive bacteria

Staphylococcus is a genus of Gram-positive bacteria in the family Staphylococcaceae from the order Bacillales. Under the microscope, they appear spherical (cocci), and form in grape-like clusters. Staphylococcus species are facultative anaerobic organisms.

<span class="mw-page-title-main">Chronic obstructive pulmonary disease</span> Lung disease involving long-term poor airflow

Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by long-term respiratory symptoms and airflow limitation. GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms due to abnormalities of the airways and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.

The lung microbiota is the pulmonary microbial community consisting of a complex variety of microorganisms found in the lower respiratory tract particularly on the mucous layer and the epithelial surfaces. These microorganisms include bacteria, fungi, viruses and bacteriophages. The bacterial part of the microbiota has been more closely studied. It consists of a core of nine genera: Prevotella, Sphingomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus, and Streptococcus. They are aerobes as well as anaerobes and aerotolerant bacteria. The microbial communities are highly variable in particular individuals and compose of about 140 distinct families. The bronchial tree for instance contains a mean of 2000 bacterial genomes per cm2 surface. The harmful or potentially harmful bacteria are also detected routinely in respiratory specimens. The most significant are Moraxella catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae. They are known to cause respiratory disorders under particular conditions namely if the human immune system is impaired. The mechanism by which they persist in the lower airways in healthy individuals is unknown.

Staphylococcus schleiferi is a Gram-positive, cocci-shaped bacterium of the family Staphylococcaceae. It is facultatively anaerobic, coagulase-variable, and can be readily cultured on blood agar where the bacterium tends to form opaque, non-pigmented colonies and beta (β) hemolysis. There exists two subspecies under the species S. schleiferi: Staphylococcus schleiferi subsp. schleiferi and Staphylococcus schleiferi subsp. coagulans.

Staphylococcus pseudintermedius is a gram positive coccus bacteria of the genus Staphylococcus found worldwide. It is primarily a pathogen for domestic animals, but has been known to affect humans as well. S. pseudintermedius is an opportunistic pathogen that secretes immune modulating virulence factors, has many adhesion factors, and the potential to create biofilms, all of which help to determine the pathogenicity of the bacterium. Diagnoses of Staphylococcus pseudintermedius have traditionally been made using cytology, plating, and biochemical tests. More recently, molecular technologies like MALDI-TOF, DNA hybridization and PCR have become preferred over biochemical tests for their more rapid and accurate identifications. This includes the identification and diagnosis of antibiotic resistant strains.

Kocuria is a genus of gram-positive bacteria. Kocuria is named after Miloslav Kocur, a Czech microbiologist. It has been found in the milk of water deer and reindeer. Cells are coccoid, resembling Staphylococcus and Micrococcus, and can group in pairs, chains, tetrads, cubical arrangements of eight, or irregular clusters. They have rigid cell walls and are either aerobic or facultative anaerobic. Kocuria can usually survive in mesophilic temperatures.

<i>Rothia</i> (bacterium) Genus of bacteria

Rothia is a Gram-positive, aerobic, rod-shaped and non-motile bacterial genus from the family Micrococcaceae. Rothia bacteria can cause disease in humans and immunosuppressed humans.

Arthrographis kalrae is an ascomycetous fungus responsible for human nail infections described in 1938 by Cochet as A. langeronii. A. kalrae is considered a weak pathogen of animals including human restricted to the outermost keratinized layers of tissue. Infections caused by this species are normally responsive to commonly used antifungal drugs with only very rare exceptions.

References

  1. Bergan T, Bøvre K, Hovig B. (1970). "Priority of Micrococcus mucilaginosus Migula 1900 over Staphylococcus salivarius Andrewes and Gordon 1907 with proposal of a neotype strain". Int J Syst Evol Microbiol. 20 (1). doi: 10.1099/00207713-20-1-107 .
  2. Bergan T, Kocur M. "Stomatococcus mucilaginosus gen. nov., sp. nov., ep. rev., a Member of the Family Micrococcaceae". Int J Syst Evol Microbiol. 32 (3). doi: 10.1099/00207713-32-3-374 .
  3. 1 2 3 4 Fanourgiakis, P.; Georgala, A.; Vekemans, M.; Daneau, D.; Heymans, C.; Aoun, M. (October 2003). "Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute". Clinical Microbiology and Infection. 9 (10): 1068–1072. doi: 10.1046/j.1469-0691.2003.00772.x . PMID   14616756.
  4. Eiff, Christof von; Herrmann, Mathias; Peters, Georg (January 1995). "Antimicrobial Susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp". Antimicrobial Agents and Chemotherapy. 39 (1): 268–270. doi:10.1128/aac.39.1.268. PMC   162524 . PMID   7695321.
  5. 1 2 3 Sadikot, Ruxana T.; Yuan, Zhihong; Panchal, Dipti; Syed, Mansoor Ali; Mehta, Hiren; Joo, Myungsoo; Hadid, Walid (October 2013). "Induction of Cyclooxygenase-2 Signaling by Stomatococcus mucilaginosus Highlights the Pathogenic Potential of an Oral Commensal". The Journal of Immunology 191 (7): 3810-3817.
  6. 1 2 Rigauts, C.; Aizawa, J.; Taylor, S.; al, et (2022-05-05). "Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease". European Respiratory Journal. 59 (5): 2101293. doi: 10.1183/13993003.01293-2021 . PMC   9068977 . PMID   34588194.
  7. Sadikot, Ruxana T.; Yuan, Zhihong; Panchal, Dipti; Syed, Mansoor Ali; Mehta, Hiren; Joo, Myungsoo; Hadid, Walid (October 2013). "Induction of Cyclooxygenase-2 Signaling by Stomatococcus mucilaginosus Highlights the Pathogenic Potential of an Oral Commensal". The Journal of Immunology. 191 (7): 3810–3817. doi: 10.4049/jimmunol.1300883 . PMID   24018272. S2CID   21828229.
  8. Ascher, David P.; Zbick, Chris; White, Chris; Fischer, Gerald W. (Dec 1991). "Infections Due to Stomatococcus mucilaginosus: 10 Cases and Review". Reviews of Infectious Diseases. 13 (6): 1048–1052. doi:10.1093/clinids/13.6.1048. PMID   1775836.